First Trust Advisors LP Lexicon Pharmaceuticals, Inc. Transaction History

First Trust Advisors LP

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2019 May 09, 2019	SELL	$4.36 - $7.94 $213,578 - $388,948	-48,986 Closed	0 $0
Q4 2018 Feb 07, 2019	SELL	$6.15 - $10.51 $577,651 - $987,172	-93,927 Reduced 65.72%	48,986 $325,000
Q3 2018 Oct 25, 2018	BUY	$10.32 - $13.06 $1.47 Million - $1.87 Million	142,913 New	142,913 $1.53 Million
Q4 2017 Feb 08, 2018	SELL	$8.77 - $12.28 $256,575 - $359,263	-29,256 Closed	0 $0
Q3 2017 Oct 24, 2017	BUY	$12.17 - $16.3 $356,045 - $476,872	29,256	29,256 $360,000

141

238M

459K

133K

Ticker LXRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 188,726,000
Market Cap $157M
Description
Lexicon Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of pharmaceutical products. Its orally-delivered small molecule drug candidates under development comprise Sotagliflozin that completed Phase III clinical trials for the for the treatment of heart failure and type 1 diabetes; ...

Get notified when there are updates to the investment portfolio of First Trust Advisors LP, based on Form 13F filings with the SEC.

Stay updated on First Trust Advisors LP with notifications on news.